메뉴 건너뛰기
Transplantation Proceedings
Volumn 40, Issue 6, 2008, Pages 1913-1915
Endolymphatic Immunotherapy in Inoperable Hepatocellular Carcinoma
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA FETOPROTEIN; INTERLEUKIN 2;
EID: 48049088815     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.049     Document Type: Article
Times cited : (12)
References (8)
  • 1
    • 0030757461 scopus 로고    scopus 로고
    • Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990
    • Black R.J., Bray F., Ferlay J., et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33 (1997) 1075
    • (1997) Eur J Cancer , vol.33 , pp. 1075
    • Black, R.J.1    Bray, F.2    Ferlay, J.3
  • 2
    • 1242307263 scopus 로고    scopus 로고
    • The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma
    • Barcelona-Clínic Liver Cancer Group
    • Llovet J.M., Fuster J., Bruix J., and Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10 2 suppl 1 (2004) S115
    • (2004) Liver Transpl , vol.10 , Issue.2 SUPPL. 1
    • Llovet, J.M.1    Fuster, J.2    Bruix, J.3
  • 3
    • 18144411666 scopus 로고    scopus 로고
    • Updated treatment approach to hepatocellular carcinoma
    • Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (2005) 225
    • (2005) J Gastroenterol , vol.40 , pp. 225
    • Llovet, J.M.1
  • 4
    • 33745448225 scopus 로고    scopus 로고
    • Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature
    • Sotiropoulos G.C., Lang H., Frilling A., et al. Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature. Hepatogastroenterology 53 (2006) 322
    • (2006) Hepatogastroenterology , vol.53 , pp. 322
    • Sotiropoulos, G.C.1    Lang, H.2    Frilling, A.3
  • 5
    • 17944377947 scopus 로고    scopus 로고
    • Immunotherapy of metastatic kidney cancer
    • Pizza G., De Vinci C., Lo Conte G., et al. Immunotherapy of metastatic kidney cancer. Int J Cancer 94 (2001) 109
    • (2001) Int J Cancer , vol.94 , pp. 109
    • Pizza, G.1    De Vinci, C.2    Lo Conte, G.3
  • 6
    • 21844444583 scopus 로고    scopus 로고
    • Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis
    • Cucchetti A., Vivarelli M., Piscaglia F., et al. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol 43 (2005) 310
    • (2005) J Hepatol , vol.43 , pp. 310
    • Cucchetti, A.1    Vivarelli, M.2    Piscaglia, F.3
  • 7
    • 0024367143 scopus 로고
    • Adoptive immunotherapy with lymphokine-activated killer cells plus recombined interleukin-2 in patients with unresectable hepatocellular carcinoma
    • Onishi S., Saibara T., and Fujikawa M. Adoptive immunotherapy with lymphokine-activated killer cells plus recombined interleukin-2 in patients with unresectable hepatocellular carcinoma. Hepatology 3 (1989) 349
    • (1989) Hepatology , vol.3 , pp. 349
    • Onishi, S.1    Saibara, T.2    Fujikawa, M.3
  • 8
    • 0027471332 scopus 로고
    • Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial
    • Lai C.L., Lau J.Y., Wu P.C., et al. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 17 (1993) 389
    • (1993) Hepatology , vol.17 , pp. 389
    • Lai, C.L.1    Lau, J.Y.2    Wu, P.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.